Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

NCT01936961 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled

Conditions

Metastatic Non-Small Cell Lung Cancer
Metastatic Colon Cancer
Metastatic Triple Negative Breast Cancer

Interventions

DRUG: CTLA-4 Antibody
RADIATION: Hypofractionated Radiotherapy

Sponsor

Western Regional Medical Center